Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

and increased activation of dendritic cells—the antigen-presenting cells that bridge innate and adaptive immunity. Without Siglec-E, dendritic cells stayed hyperactivated, producing more pro ...

Tissue-specific immune memory has become a central focus in immunology, drawing attention to the distinct roles of tissue-resident memory lymphocytes, their ...

A peptide with a dual mechanism of action – it dissolves the bacterial membrane and activates the immune system – could be an ...

Pulmonary fibrosis encompasses a spectrum of interstitial lung diseases (ILDs) characterized by chronic inflammation, aberrant tissue remodeling, and ...

Cardiovascular diseases (CVDs) continue to dominate global mortality statistics, with immune dysregulation emerging as a central feature in their ...